Ivan Martin is a Professor at the University of Basel and the Director of the Department of Biomedicine at the University of Basel in Switzerland. He is the Head of the Tissue Engineering Research Group; his group includes scientists from biological, engineering and clinical fields, dedicated to developing a solid scientific basis for innovative, translational strategies in regenerative surgery.
In this field he is author of more than 300 peer-reviewed papers in international journals (H-Index:94), member of editorial boards of 6 international journals and inventor for 10 patent applications; as well as receiving various European research grants, including the European Research Council (ERC). The science and technologies developed by his team have been translated into different clinical trials for cell-based cartilage and bone repair, and into the founding of a spin-out company for the commercialization of bioreactors for 3D cell culture (Cellec Biotek AG).